SPONSOR
Eye & ENT Hospital of Fudan University
Total Trials
6
Recruiting
6
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Adenoid Cystic CarcinomaSinonasal CarcinomaRetinoblastomaRetinoblastoma, RecurrentMalignant Tumor of Lacrimal Drainage StructureEsotropiaHearing LossGenetic DiseaseSpeech PerceptionRefractory
Eye & ENT Hospital of Fudan University is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Adenoid Cystic Carcinoma, Sinonasal Carcinoma, Retinoblastoma, Retinoblastoma, Recurrent.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Eye & ENT Hospital of Fudan University
How many clinical trials has Eye & ENT Hospital of Fudan University sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Eye & ENT Hospital of Fudan University, of which 6 are actively recruiting participants. These trials cover conditions including Adenoid Cystic Carcinoma, Sinonasal Carcinoma, Retinoblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Eye & ENT Hospital of Fudan University research focus on?
Eye & ENT Hospital of Fudan University clinical trials span Adenoid Cystic Carcinoma, Sinonasal Carcinoma, Retinoblastoma, Retinoblastoma, Recurrent, Malignant Tumor of Lacrimal Drainage Structure, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Eye & ENT Hospital of Fudan University clinical trial?
To participate in a Eye & ENT Hospital of Fudan University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Eye & ENT Hospital of Fudan University trials with current recruitment status updated daily.
Clinical Trials by Eye & ENT Hospital of Fudan University
NCT07522879 Phase 2
Recruiting
A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
NCT06972602 EARLY_Phase 1
Recruiting
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Retinoblastoma
NCT04016675
Recruiting
Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors
Malignant Tumor of Lacrimal Drainage Structure
NCT06622044
Recruiting
Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
Esotropia
NCT06237790
Recruiting
Auditory Restoration and Outcomes After Gene Therapy and Cochlear Implantation: a PRospective Cohort Analysis (AURORA)
Hearing Loss
NCT06424301 EARLY_Phase 1
Recruiting
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Retinoblastoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology